Proposed cuts to the National Institutes of Health and the National Science Foundation “would cause immense and largely ...

People are going on social media to share their belief that this antiparasitic drug can fight cancer. Learn what the science ...

SGT-501 is a novel gene therapy for rare, life-threatening, genetic arrhythmogenic disease with no approved therapies - - SGT-501 has received Orphan Drug Designation and Rare Pediatric Disease Design ...

The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this ...

After nearly 15 years' research, scientists at the UdeM-affiliated CHU Sainte-Justine have developed a compound that has ...

Groundbreaking research by Sydney University found a new brain protein involved in Parkinson’s disease and a way to modify it ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

This could lead to the development of precision allergy treatments that are fast acting, needle free, and tailored to individual allergen sensitivities.

A groundbreaking study led by Prof. Bo Peng at Fudan University demonstrates that microglia replacement effectively halts the ...

An analytical approach increases spatiotemporal resolution, optimizes real-time, in vivo detection of Met- and Leu-enkephalin, and provides novel insight into the relationship between Met- and ...

Cardiovascular disease exhibits distinct sex-based differences, yet the mechanisms underlying these differences remain under-explored. The pro-resolving mediator annexin-A1 (ANXA1) is a pivotal ...